Department of Cardiology, the Second Xiangya Hospital of Central South University, China.
Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg University, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Sweden.
Int Immunopharmacol. 2019 Sep;74:105733. doi: 10.1016/j.intimp.2019.105733. Epub 2019 Jul 6.
Takotsubo syndrome (TS) is an acute cardiac syndrome that mimics acute coronary syndrome (ACS) but lacks coronary obstruction and is associated with sudden physical or psychiatric episodes. Several hypotheses have been proposed for the TS mechanism, but the precise cause of this syndrome remains poorly known. Recent studies noted TS patients with acute endogenous catecholamine discharge, which could trigger an oxidative stress response and inflammatory action.
A single dose of the selective β-adrenergic agonist isoprenaline (ISO) was used to induce a takotsubo-like (TS-like) model. Different icariin or metoprolol doses were supplied as cardioprotective agents by intragastric administration (IG), and lipopolysaccharides (LPS) were assessed to investigate the possible mechanism of action of icariin. Transthoracic echocardiography was used to study cardiac function and morphology. The amounts of intracellular lipids and myocardial fibrosis, which represent the degree of cardiac impairment, were assessed by histological analysis. Real-time polymerase chain reaction (RT-PCR) was performed to analyze a variety of anti-oxidant elements and inflammatory factors, and Western blotting was conducted to analyze the expression of signaling pathway proteins involved in the development of TS.
The TS-like incidence in rats was lowest with icariin precondition at 2-h post-ISO administration, and both the left ventricular ejection fraction (LVEF) and ejection volume per minute were higher than those of the other groups. However, LPS administration increased the incidence of TS and aggravated cardiac impairment. Moreover, ISO significantly increased the levels of both reactive oxygen species (ROS) and TLR4/NF-κB signaling pathway proteins compared to those of the Sha-group, whereas icariin remarkably decreased the ROS levels and increased anti-oxidant element expression while reducing pro-inflammatory factor secretion and suppressing TLR4/NF-κB signaling pathway protein expression. However, the cardioprotective effect of icariin was significantly weakened by combining treatment with LPS.
Icariin prevented ISO-induced TS-like cardiac dysfunction in rats. The effects were induced mainly through maintenance of the dynamic balance of the ROS system, promotion of anti-oxidant element activity, and suppression of TLR4/NF-κB signaling pathway protein expression. Furthermore, the ability of icariin to increase anti-inflammatory and reduce pro-inflammatory factor secretion may be involved in the protective process.
Takotsubo 综合征(TS)是一种类似于急性冠状动脉综合征(ACS)的急性心脏综合征,但缺乏冠状动脉阻塞,与突然的身体或精神发作有关。已经提出了几种关于 TS 机制的假说,但这种综合征的确切原因仍知之甚少。最近的研究注意到 TS 患者存在急性内源性儿茶酚胺释放,这可能引发氧化应激反应和炎症作用。
使用单次剂量的选择性β-肾上腺素能激动剂异丙肾上腺素(ISO)诱导 Takotsubo 样(TS 样)模型。通过胃内给药(IG)提供不同剂量的淫羊藿苷或美托洛尔作为心脏保护剂,并评估脂多糖(LPS)以研究淫羊藿苷的可能作用机制。经胸超声心动图用于研究心脏功能和形态。通过组织学分析评估代表心脏损伤程度的细胞内脂质和心肌纤维化的量。实时聚合酶链反应(RT-PCR)用于分析各种抗氧化元素和炎症因子,Western blot 用于分析参与 TS 发展的信号通路蛋白的表达。
在 ISO 给药后 2 小时给予淫羊藿苷预处理时,大鼠 TS 样发生率最低,左心室射血分数(LVEF)和每分钟射血量均高于其他组。然而,LPS 给药增加了 TS 的发生率并加重了心脏损伤。此外,与 Sha 组相比,ISO 显著增加了活性氧(ROS)和 TLR4/NF-κB 信号通路蛋白的水平,而淫羊藿苷显著降低了 ROS 水平,增加了抗氧化元素的表达,同时减少了促炎因子的分泌,并抑制了 TLR4/NF-κB 信号通路蛋白的表达。然而,LPS 联合治疗显著削弱了淫羊藿苷的心脏保护作用。
淫羊藿苷可预防 ISO 诱导的大鼠 TS 样心脏功能障碍。这些作用主要是通过维持 ROS 系统的动态平衡、促进抗氧化元素的活性以及抑制 TLR4/NF-κB 信号通路蛋白的表达来实现的。此外,淫羊藿苷增加抗炎和减少促炎因子分泌的能力可能参与了保护过程。